Sugimoto Yoshikazu | Division Of Gene Therapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
スポンサーリンク
概要
- SUGIMOTO Yoshikazuの詳細を見る
- 同名の論文著者
- Division Of Gene Therapy Cancer Chemotherapy Center Japanese Foundation For Cancer Researchの論文著者
関連著者
-
Sugimoto Yoshikazu
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Sugimoto Yoshikazu
Division Of Gene Therapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Sugimoto Yoshikazu
Department Of Gene Therapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Mitsuhashi Junko
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Shiba T
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Takahashi Shunji
Cancer Inst. Hospital Tokyo Jpn
-
Tsuruo Takashi
The Cancer Chemotherapy Center Japanese Foundation For Cancer Research (jfcr)
-
Takahashi Shunji
Department Of Oncology And Hematology Cancer Institute Hospital
-
Tsuruo T
Japanese Foundation For Cancer Research Tokyo Jpn
-
Tsukahara Satomi
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Tsukahara Satomi
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Katayama Kazuhiro
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Sugimoto Yoshikazu
Division Of Chemotherapy Keio University
-
Tsuruo Takashi
Division Of Molecular Oncology Aichi Cancer Center Research Institute
-
Shiba Tadayoshi
Department Of Molecular Biology Kitasato University
-
Noguchi Kohji
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Katayama Kazuhiro
Division Of Cardiology Department Of Medicine School Of Medicine University Of California
-
Tsuruo T
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese
-
Terui Shoji
国立がんセンター中央病院
-
Sato Takaaki
Division Of Surgery Tochigi Cancer Center Hospital
-
Tajiri T
Department Of Surgery I Nippon Medical School
-
TSUKAHARA Satomi
Division of Gene Therapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
SUGIMOTO Yoshikazu
Department of Gene Therapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
TAKAYAMA Shin
Department of Surgery
-
KATAYAMA KAZUHIRO
Division of cardiology, Department of Medicine, School of Medicine, University of California
-
SUGIMOTO Yoshikazu
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Sone S
Department Of Internal Medicine And Molecular Therapeutics Institute Of Health Biosciences Universit
-
Tsuruo T
The Cancer Chemotherapy Center Japanese Foundation For Cancer Research (jfcr)
-
Sato Shigeo
The Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
SUGIMOTO Yoshikazu
Department of Chemotherapy, Faculty of Pharmacy, Keio University
-
Taniguchi Tetsuo
The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR)
-
SUGIMOTO Yoshikazu
Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Researc
-
Hatake Kiyohiko
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Hatake Kiyohiko
Division Of Medical Oncology Cancer Institute Hospital
-
ISHIKAWA Etsuko
Division of Gene Therapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
TSURUO Takashi
Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Re
-
TSURUO Takashi
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Ito Yoshinori
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
SATO Shigeo
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Sato Shinji
Division Of Advanced Surgical Science And Technology Tohoku University Graduate School Of Medicine
-
Tsuruo Takashi
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese
-
Tsuruo Takashi
Cancer Chemotherapy Center
-
Tsuruo Takashi
Director's Room Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Ito Yoshinori
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Sato S
Division Of Advanced Surgical Science And Technology Tohoku University Graduate School Of Medicine
-
Tsuruo T
Director's Room Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Hatake Kiyohiko
Olympus Bio-imaging Laboratory The Cancer Chemotherapy Center Of The Jfcr
-
KAWAHARA Haruka
Division of Chemotherapy, Faculty of Pharmacy, Keio University
-
Kawahara Haruka
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Ishikawa Etsuko
Division Of Gene Therapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Ito Yoshinori
Departments Of Pathology Medical Oncology And Breast Oncology The Cancer Institute Hospital Of The J
-
Ito Yoshinori
Department Of Breast Oncology The Cancer Institute Hospital Of The Japanese Foundation For Cancer Research
-
ITO Yoshinori
Department of Public Health, Fujita Health University School of Health Sciences
-
AIBA Keisuke
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
TSURUO TAKASHI
Institute of Molecular and Cellular Biosciences, University of Tokyo
-
Aiba Keisuke
癌研究会癌化学療法センター 臨床研究部
-
Aiba Keisuke
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Takeuchi Kengo
Cancer Inst. Hospital Tokyo Jpn
-
Kobayashi Takayuki
Cancer Inst. Hospital Tokyo Jpn
-
MIYATA Satoshi
Genome Center, Japanese Foundation for Cancer Research
-
MATSUURA Masaaki
Genome Center, Japanese Foundation for Cancer Research
-
TAKAHASHI SHUNJI
Department of Anesthesiology, Nagasaki University School of Medicine
-
Hatake Kiyohiko
Department Of Hematology Jichi Medical School
-
Aiba Keisuke
Department Of Medical Oncology Cancer Institute Hospital
-
Oh‐hara T
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Suzuki Rieko
Division Of Gene Therapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Andoh Toshiwo
Department Of Hygienic Chemistry Meiji College Of Pharmacy
-
Andoh Toshiwo
Department Of Bioengineering Faculty Of Engineering Soka University
-
TAKAHASHI Shunji
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
ITO Yoshinori
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
NAKANE Minoru
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
KOBAYASHI Takayuki
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
MINOWA Sayuri
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
SHIBATA Harumi
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
MITSUHASHI Junko
Division of Gene Therapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Fujita Naoya
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese
-
TSURUO Takashi
Director's Room, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
TSUKAHARA Satomi
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
SONE Saburo
Third Department of Internal Medicine, University of Tokushima School of Medicine
-
SHINOHARA Tsutomu
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
OH-HARA Tomoko
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Shinohara Tsutomu
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Oh-hara Tomoko
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Tsuruo Takashi
Institute Of Molecular And Cellular Biosciences The University Of Tokyo
-
Hirata Kouichi
First Department Of Surgery Sapporo Medical College
-
Tsuruo T
Division Of Molecular Oncology Aichi Cancer Center Research Institute
-
Sone Saburo
Third Department Of Internal Medicine School Of Medicine Tokushima University
-
Minowa Sayuri
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Nakane Minoru
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Shibata Harumi
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Miyata Satoshi
Genome Center Japanese Foundation For Cancer Research
-
Bando Toshikazu
Department Of Chemistry Graduate School Of Science Kyoto University
-
KATAYAMA Ryohei
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
KOIKE Sumie
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
FUJITA Naoya
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
MASHIMA Tetsuo
Division of Molecular Biotherapy, The Cancer Institute, Japanese Foundation for Cancer Research
-
SATO Shigeo
Experimental Chemotherapy, Cancer Chemotherapy Center, The Cancer Institute, Japanese Foundation for
-
OKABE Sachiko
Division of Molecular Biotherapy, The Cancer Institute, Japanese Foundation for Cancer Research
-
SEIMIYA Hiroyuki
Division of Molecular Biotherapy, The Cancer Institute, Japanese Foundation for Cancer Research
-
Koike Sumie
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Kasahara T
Department Of Biochemistry Kyoritsu University Of Pharmacy
-
Takahashi Shunji
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Takahashi Shunji
Department Of Anesthesiology Nagasaki University School Of Medicine
-
Okabe Sachiko
Division Of Molecular Biotherapy The Cancer Institute Japanese Foundation For Cancer Research
-
Miyata Satoshi
Genome Center The Cancer Institute Japanese Foundation For Cancer Research
-
Fujita Naoya
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Hatake Kiyohiko
Department Of Medical Oncology Ariake Cancer Institute Hospital
-
Katayama Kazuhiro
Department Of Gastroenterology And Hepatology Osaka Koseinenkin Hospital
-
Tsukahara Satomi
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
IMAI Yasuo
Division of Molecular Bioherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
YANASE Kae
Cancer Chemotherapy Center Japanese Foundation for Cancer Research
-
Matsuura Masaaki
Genome Center Japanese Foundation For Cancer Research
-
Matsuura Masaaki
Genome Center The Cancer Institute Japanese Foundation For Cancer Research
-
Minoshima Masafumi
Department Of Chemistry Graduate School Of Science Kyoto University
-
Mashima Tetsuo
Division Of Molecular Biotherapy The Cancer Institute Japanese Foundation For Cancer Research
-
Katayama Ryohei
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
MUTOH Kazuyoshi
Department of Chemotherapy, Kyoritsu University of Pharmacy
-
MITSUHASHI Junko
Department of Chemotherapy, Kyoritsu University of Pharmacy
-
Takahashi Kaoru
Department Of Breast Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
SHIGETA Junichi
Division of Chemotherapy, Faculty of Pharmacy, Keio University
-
KAJI Airi
Division of Chemotherapy, Graduate School of Pharmaceutical Sciences, Keio University
-
Imai Yasuo
Division Of Molecular Bioherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Kaji Airi
Division Of Chemotherapy Graduate School Of Pharmaceutical Sciences Keio University
-
Ito Yoshinori
Department Of Biomedical Food Research National Institute Of Infectious Diseasea(former National Ins
-
Mutoh Kazuyoshi
Department Of Chemotherapy Kyoritsu University Of Pharmacy
-
Shigeta Junichi
Division Of Chemotherapy Faculty Of Pharmacy Keio University
-
Ito Yoshinori
Department Of Biochemistry Nagoya City University Medical School
-
Kobayashi Takayuki
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Ito Yoshinori
Division Of Central Clinical Laboratory Nagoya City University Hospital
-
Seimiya Hiroyuki
Division Of Molecular Biotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Seimiya Hiroyuki
Division Of Molecular Biotherapy The Cancer Institute Japanese Foundation For Cancer Research
-
Takagi Koichi
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Sugiyama Hiroshi
Department Of Chemistry Faculty Of Science
-
YASUDA Ai
Division of Chemotherapy, Keio University
-
KASHIWAZAKI Gengo
Department of Chemistry, Kyoto University
-
KANDA Teru
Division of Virology, Aichi Cancer Center Research Institute
-
Yasuda Ai
Division Of Chemotherapy Keio University
-
Kanda Teru
Division Of Virology Aichi Cancer Center Research Institute
-
Kashiwazaki Gengo
Department Of Chemistry Kyoto University
-
Sugiyama Hiroshi
Department Of Chemistry Kyoto University
-
Okabe Sachiko
Division Of Molecular Biotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
著作論文
- Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
- Gene Therapy for Breast Cancer.-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital
- Combination Therapy with Antibody and Interleukin-2 Gene Transfer against Multidrug-resistant Cancer Cells
- Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export
- Acyl-CoA synthetase as a cancer survival factor : its inhibition enhances the efficacy of etoposide
- Estrone and 17β-Estradiol Reverse Breast Cancer Resistance Protein-mediated Multidrug Resistance
- Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma
- Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells
- BCRP/ABCG2 confers anticancer drug resistance without covalent dimerization
- Pharmacological interaction with sunitinib is abolished by a germ-line mutation (1291T>C) of BCRP/ABCG2 gene
- Substrate-dependent bidirectional modulation of P-glycoprotein-mediated drug resistance by erlotinib
- DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization